Lions Eye Institute

Last updated

Lions Eye Institute (Australia)
Lyons Eye Institute logo.jpg
MottoBetter vision for all
Founder(s)Professor Ian Constable AO
Established1983;40 years ago (1983)
Mission Medical research
Focus Eye disease
Chair Tony Joyner
Managing DirectorProfessor Bill Morgan
Faculty University of Western Australia
Key peopleTony Joyner (Chairman)
Bill Morgan (Managing Director)
Glen Power (Chief Executive Officer)
Leeanne Thomas (Chief Financial Officer)
Wendy Murray (Director, Research Strategy and Innovation)
JoAnne Forrest (Director Clinical Research)
Angus Turner (McCusker Director Lions Outback Vision)
Location
Nedlands
,
Perth
,
Western Australia
,
Australia
Website www.lei.org.au

The Lions Eye Institute (LEI) is an Australian medical research institute affiliated with the University of Western Australia. It was established in 1983 with support of the Lions Clubs of Western Australia and headquartered in the Perth suburb of Nedlands , Western Australia. The LEI is a not-for-profit centre of excellence that combines an ophthalmic clinic with scientific discovery developing techniques for the prevention of blindness and the reduction of pain from blinding eye conditions. [1] [2]

Contents

History

At a 1970 convention in Albany, Western Australia, the Western Australian Lions Clubs created the Lions Save Sight Foundation (WA) Inc. with the aim of leading the development of ophthalmic care. [3] In 1975 the Lions Save-Sight Foundation (LSSF) established the Lions Chair in Ophthalmology at the University of Western Australia. Since its establishment, clinical facilities, new equipment, and research laboratories have been strategically commissioned to support the LEI's core activities. In 1983, under Professor Ian Constable's guidance, the LEI, a not-for-profit organisation was established. [4] [5] With Constable, the LEI became an international centre for scientific research into blindness. Following its development, it relocated to the grounds of Sir Charles Gairdner Hospital. Its current Managing Director Bill Morgan leads a team of clinicians, medical professionals, researchers and support staff. In 1994, the Institute created in partnership with the University of Western Australia, the Centre for Ophthalmology and Visual Science (COVS). This centre has an independent University status within the Faculty of Medicine and Dentistry. In 2003, the LEI revised its basis of incorporation from a public benevolent charitable institution to a not-for profit limited liability company.

Overview

The LEI employs scientists, clinicians, and support staff to conduct scientific research into blindness with known ophthalmic practices in Australia. The Institute also includes a Laser Vision Centre, Western Australia's refractive surgery centre; the Lions Eye Bank, Lions Outback Vision, Lions Optics and the LSSF. The LEI actively participates in numerous clinical trials for the development of new treatments for eye diseases, in collaboration with scientists, ophthalmologists, and pharmaceutical companies. The Institute receives funds from clinic operations and its grants from organisations such as the National Health and Medical Research Council, individual benefactors and the LSSF. [6]

Services

The LEI provides a range of services including standard clinical services, LASIK surgery at the Lions Laser Vision Center, cataract micro-surgery and lens implantation, plastic surgery of the eyelids and full optometric service at Lions Optics. The Lions Eye Bank collects and distributes corneal tissue, scleral tissue and supplies thousands of corneal transplants throughout Western Australia. [7] The Institute initiated the Pilbara Aboriginal Eye Health Program, a strategy targeting indigenous people who suffer from diabetes and associated blinding eye diseases prevalent within the Aboriginal population. [8] As part of the Australian Government aid to the Indonesian Government, [9] In July 2007, the LEI was instrumental in setting up the Bali Mandara Eye Hospital which was handed over to the Indonesian Government on 13 October 2015. [2] The LEI provides open consultations and health education seminars in cooperation with several organisations including Glaucoma Australia, Retinitis Pigmentosa Society of Western Australia, Macular Degeneration Foundation and the Australian Foundation for the Prevention of Blindness. Its ophthalmologists also consult at Perth's main teaching public hospitals including Sir Charles Gairdner Hospital, Royal Perth Hospital and Fremantle Hospital.

Research Activities

The LEI teams investigate all major causes of blindness including cataracts, diabetes related eye disease, glaucoma, retinal degenerations, corneal, and immune-based diseases. More than 70 scientists at the LEI use a range of technologies to develop treatments for blinding diseases, including gene therapy and telemedicine. [6] The LEI has national and international institutional partnerships including American Juvenile Diabetes Foundation, Shanghai University, Swedish University of Agricultural Science, University of Missouri and the National Eye Institute (USA). For example, the LEI participates in joint research and development projects with the American Juvenile Diabetes Foundation, Swedish University of Agricultural Sciences, University of Missouri and the National Eye Institute (USA). [10] Research carried out by the Institute teams led to the first retinal vein bypass treatment of blockages, [11] and the development of the first transgenic mouse model for Age-Related Macular Degeneration, the leading cause of blindness for people over 55. This model is expected to accelerate the development of ARMD leading to an effective treatment. At the LEI, the first artificial cornea, the AlphaCor was developed and implanted into a human eye. [12] The LEI is acknowledged as a core academic centre involved in clinical trials of new pharmaceutical therapies and surgical procedures before government approval. For example, the Xen Gel Stent, an implantable transcleral microsurgical device developed at the LEI was approved for use in the US by the FDA in 2016. [13]

See also

Related Research Articles

<span class="mw-page-title-main">Ophthalmology</span> Field of medicine treating eye disorders

Ophthalmology is a surgical subspecialty within medicine that deals with the diagnosis and treatment of eye disorders.

<span class="mw-page-title-main">Diabetic retinopathy</span> Medical condition

Diabetic retinopathy, is a medical condition in which damage occurs to the retina due to diabetes mellitus. It is a leading cause of blindness in developed countries.

The National Eye Institute (NEI) is part of the U.S. National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. The mission of NEI is “to eliminate vision loss and improve quality of life through vision research.” NEI consists of two major branches for research: an extramural branch that funds studies outside NIH and an intramural branch that funds research on the NIH campus in Bethesda, Maryland. Most of the NEI budget funds extramural research.

This is a partial list of human eye diseases and disorders.

Ian Jeffrey Constable is an Australian ophthalmologist and the founder and director of the Lions Eye Institute in Perth, Western Australia. He was the Foundation Lions Professor of Ophthalmology at the University of Western Australia, and the Foundation Director of UWA's Centre for Ophthalmology and Visual Science. He is now Patron of the Lions Eye Institute.

Robert G. Devenyi FRCSC, FACS is a vitreoretinal surgeon and Professor of Ophthalmology and Vision Sciences at the University of Toronto. He is also the team ophthalmologist for the Toronto Maple Leafs of the National Hockey League. Devenyi is Ophthalmologist-in-Chief and Director of Retinal Services at the University Health Network (UHN), which is affiliated with the University of Toronto. Devenyi is also the co-director of the Donald K. Johnson Eye Institute located at the Toronto Western Hospital, part of UHN. The DKJ Eye Institute is one of Canada's subspecialty ophthalmology facility.

The Donald K. Johnson Eye Centre is Canada's largest clinical and research institute for vision. It is located in Toronto at the Toronto Western Hospital.

<span class="mw-page-title-main">AMD Alliance International</span>

AMD Alliance International is a non-profit coalition of the world’s leading vision, seniors and research organizations working to raise awareness of age-related macular degeneration, understanding of available options for prevention, early detection, treatment, rehabilitation and support services. It is the only international organization in the world that concentrates exclusively on age related macular degeneration, the leading cause of vision loss in the developed world.

A visual prosthesis, often referred to as a bionic eye, is an experimental visual device intended to restore functional vision in those with partial or total blindness. Many devices have been developed, usually modeled on the cochlear implant or bionic ear devices, a type of neural prosthesis in use since the mid-1980s. The idea of using electrical current to provide sight dates back to the 18th century, discussed by Benjamin Franklin, Tiberius Cavallo, and Charles LeRoy.

<span class="mw-page-title-main">Foundation Fighting Blindness</span>

The mission of the Foundation Fighting Blindness is to fund research that will lead to the prevention, treatment and cures for the entire spectrum of retinal degenerative diseases, including retinitis pigmentosa, macular degeneration, Usher syndrome, Stargardt disease and related conditions. These diseases, which affect more than 10 million Americans and millions more throughout the world, often lead to severe vision loss or complete blindness.

Bascom Palmer Eye Institute is the University of Miami School of Medicine's ophthalmic care, research, and education center. The institute is based in the Health District of Miami, Florida, and has been ranked consistently as the best eye hospital and vision research center in the nation.

The Universitäts-Augenklinik Düsseldorf is the department of Ophthalmology of the University Hospital of Düsseldorf in Germany. It is an internationally renown centre for corneal transplantation, ocular surface disease and management of associated disorders ranging from Glaucoma to oculoplastic surgery. Further subspecialist expertise is established for the diagnosis and surgical and medical treatment of vitreoretinal and macular disorders as well as strabismus.

<span class="mw-page-title-main">John Marshall (eye laser scientist)</span> British medical scientist and inventor

John Marshall MBE, FMedSci, PhD, DSc, FRCPath, FRSB, FRCOphth(Hon), FRCOptom (Hon), FARVO is a British medical scientist and inventor. Currently he is the Frost Professor of Ophthalmology at the Institute of Ophthalmology UCL and Emeritus Professor King's College London. He is a pioneer of laser eye surgery.

Alan Charles Bird is an English ophthalmologist, famous for his work on degenerative and hereditary diseases of the retina.

<span class="mw-page-title-main">Robert MacLaren</span> British ophthalmologist

Robert E. MacLaren FMedSci FRCOphth FRCS FACS VR is a British ophthalmologist who has led pioneering work in the treatment of blindness caused by diseases of the retina. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a Consultant Ophthalmologist at the Oxford Eye Hospital. He is also an Honorary Consultant Vitreo-retinal Surgeon at the Moorfields Eye Hospital. MacLaren is an NIHR Senior Investigator, or lead researcher, for the speciality of Ophthalmology. In addition, he is a member of the research committee of Euretina: the European Society of Retina specialists, Fellow of Merton College, in Oxford and a Fellow of the Higher Education Academy.

Noemi Lois is a Clinical Professor of Ophthalmology at Queen's University Belfast and an Honorary Consultant Ophthalmologist and Vitreoretinal Surgeon at the Belfast Health and Social Care Trust.

<span class="mw-page-title-main">Paul A. Sieving</span>

Paul A. Sieving is a former director of the National Eye Institute, part of the U.S. National Institutes of Health. Prior to joining the NIH in 2001, he served on the faculty of the University of Michigan Medical School as the Paul R. Lichter Professor of Ophthalmic Genetics. He also was the founding director of the Center for Retinal and Macular Degeneration in the university's Department of Ophthalmology and Visual Sciences. 

Professor Robyn Guymer was awarded an Elizabeth Blackburn Fellowship from the NHMRC, and works in ophthalmology at Melbourne University. Guymer is a senior retinal specialist within the Royal Victorian Eye and Ear Hospital, and is the deputy director, Centre for Eye Research Australia. She works in age-related macular degeneration as a clinician, academic, and researcher, and has used nano-lasers to treat Age-related Macular Degeneration.

<span class="mw-page-title-main">Stem cell therapy for macular degeneration</span> Use of stem cells to treat macular degeneration

Stem cell therapy for macular degeneration is the use of stem cells to heal, replace dead or damaged cells of the macula in the retina. Stem cell based therapies using bone marrow stem cells as well as retinal pigment epithelial transplantation are being studied. A number of trials have occurred in humans with encouraging results.

<span class="mw-page-title-main">Peter Szurman</span> German ophthalmologist

Peter Szurman is a German ophthalmologist, scientist, and professor of ophthalmology in Sulzbach/Saar.

References

  1. ↑ "Scientists restore sight of mice and dogs". Sydney Morning Herald . 20 April 2005.
  2. 1 2 "Australia hands over Bali eye facility to Indonesian Government". Australian Embassy Indonesia. 14 December 2013.
  3. ↑ "History". Lions SaveSight Foundation.
  4. ↑ "Lions Eye Institute – History".
  5. ↑ "Professor David A Mackey". Our people. Lions Eye Institute. 2013. Retrieved 16 September 2016.
  6. 1 2 "LEI 2016 Annual Report" (PDF). LEI. 2016.
  7. ↑ "Services at the LEI". Archived from the original on 27 November 2012.
  8. ↑ "Improving outcomes for Aboriginal and Torres Strait Islander eye health and vision care" (PDF). June 2010.[ permanent dead link ]
  9. ↑ "Australia hands over Bali eye facility to Indonesian Government". 13 October 2015. Retrieved 12 November 2015.
  10. ↑ "Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration (AMD)". U. S. National Institutes of Health. Retrieved 1 June 2012.
  11. ↑ "'Bypass' may lead to vision gains for central retinal vein occlusion patients". Science Daily. 6 May 2010.
  12. ↑ C R Hicks; G J Crawford; X Lou; D T Tan; G R Snibson; G Sutton; N Downie; L Werner; T V Chirila; I J Constable (November 2003). "Corneal replacement using a synthetic hydrogel cornea, AlphaCor™: device, preliminary outcomes and complications" (PDF). Eye. 17 (3): 385–392. doi: 10.1038/sj.eye.6700333 . PMID   12724702.
  13. ↑ "Review of Optometry" (PDF). Springer Verlag.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.